|
HOUSE OF REPRESENTATIVES |
H.B. NO. |
1864 |
|
THIRTY-THIRD LEGISLATURE, 2026 |
H.D. 1 |
|
|
STATE OF HAWAII |
|
|
|
|
|
|
|
|
||
|
|
||
A BILL FOR AN ACT
RELATING TO INSURANCE.
BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF HAWAII:
SECTION 1. Chapter 431, Hawaii Revised Statutes, is amended by adding a new section to article 10A, part I, to be appropriately designated and to read as follows:
"§431:10A- Standard fertility preservation services coverage. (a) Each individual or group policy of accident
and health or sickness insurance issued or renewed in the State after
December 31, 2026, shall provide to the policyholder or any dependent of
the policyholder who is covered under the policy, coverage for standard
fertility preservation services for any insured who may undergo a medically
necessary treatment that may directly or indirectly cause iatrogenic
infertility.
(b) No policy that provides coverage for standard fertility preservation services as required by subsection (a) shall:
(1) Use any prior
diagnosis or prior fertility treatment as a basis for excluding, limiting, or
otherwise restricting the availability of the required coverage; or
(2) Discriminate
based on the insured's expected length of life, present or predicted
disability, degree of medical dependency, perceived quality of life, or other
health conditions.
(c) Except as provided in subsection (b), any
limitations imposed by a policy shall be based on the insured's medical history
and clinical guidelines adopted by the insurer.
Any clinical guidelines used by the insurer shall be based on the most
recent American Society of Clinical Oncology guidelines and shall not deviate
from the full scope of the guidelines.
(d) For the purposes of this section:
"American Society of
Clinical Oncology guidelines" means the clinical practice guidelines on
fertility preservation in people with cancer published by the American Society
of Clinical Oncology.
"Iatrogenic infertility" means an impairment of fertility caused directly or indirectly by surgery, chemotherapy, radiation, or other medical treatment affecting the reproductive organs or processes.
"Medically necessary
treatment that may directly or indirectly cause iatrogenic infertility"
means any cancer‑related medical treatment with a likely side effect of
infertility.
"Standard fertility
preservation services" means the procedures to preserve fertility as
outlined and established according to the most recent American Society of
Clinical Oncology guidelines.
"Standard fertility preservation services" include the full
scope of services or treatments, without any exclusions or limitations, as
defined in the most recent American Society of Clinical Oncology
guidelines. "Standard
fertility preservation services" does not include:
(1) Any
experimental procedures or other procedures not determined to be established
medical practices according to the most recent American Society of Clinical
Oncology guidelines;
(2) Third-party assisted
reproduction technology procedures, including donor egg, sperm retrieval, or
surrogates and gestational carriers; and
(3) Any services relating to cryopreservation storage."
SECTION 2. Chapter 432, Hawaii Revised Statutes, is amended by adding a new section to article I, part VI, to be appropriately designated and to read as follows:
"§432:1- Standard fertility preservation services coverage. (a) Each individual or group hospital or medical
service plan contract issued or renewed in this State after December 31,
2026, shall provide to the subscriber or member or any dependent of the
subscriber or member who is covered under the plan contract, coverage for
standard fertility preservation services for any covered person who may undergo
a medically necessary treatment that may directly or indirectly cause
iatrogenic infertility.
(b) No plan contract that provides
coverage for standard fertility preservation services as required by subsection
(a) shall:
(1) Use any prior diagnosis or prior fertility treatment as a basis for excluding, limiting, or otherwise restricting the availability of the required coverage; or
(2) Discriminate based on the covered person's expected length of life, present or predicted disability, degree of medical dependency, perceived quality of life, or other health conditions.
(c) Except as provided in subsection (b), any limitations imposed by a plan contract shall be based on the covered person's medical history and clinical guidelines adopted by the mutual benefit society. Any clinical guidelines used by the mutual benefit society shall be based on the most recent American Society of Clinical Oncology guidelines and shall not deviate from the full scope of the guidelines.
(d) For the purposes of this section:
"American Society of
Clinical Oncology guidelines" means the clinical practice guidelines on
fertility preservation in people with cancer published by the American Society
of Clinical Oncology.
"Iatrogenic infertility" means an impairment of fertility caused directly or indirectly by surgery, chemotherapy, radiation, or other medical treatment affecting the reproductive organs or processes.
"Medically necessary treatment that may directly or indirectly cause iatrogenic infertility" means any cancer‑related medical treatment with a likely side effect of infertility.
"Standard fertility
preservation services" means the procedures to preserve fertility as
outlined and established according to the most recent American Society of
Clinical Oncology guidelines.
"Standard fertility preservation services" include the full
scope of services or treatments, without any exclusions or limitations, as
defined in the most recent American Society of Clinical Oncology
guidelines. "Standard fertility
preservation services" does not include:
(1) Any
experimental procedures or other procedures not determined to be established
medical practices according to the most recent American Society of Clinical
Oncology guidelines;
(2) Third-party assisted
reproduction technology procedures, including donor egg, sperm retrieval, or
surrogates and gestational carriers; and
(3) Any services relating to cryopreservation storage."
SECTION 3. Section 432D-23, Hawaii Revised Statutes, is amended to read as follows:
"§432D-23 Required provisions and
benefits. Notwithstanding any
provision of law to the contrary, each policy, contract, plan, or agreement
issued in the State after January 1, 1995, by health maintenance organizations
pursuant to this chapter, shall include benefits provided in sections
431:10-212, 431:10A-115, 431:10A-115.5, 431:10A-116, 431:10A-116.2,
431:10A-116.5, 431:10A-116.6, 431:10A-119, 431:10A-120, 431:10A-121,
431:10A-122, 431:10A-125, 431:10A-126, 431:10A-132, 431:10A-133, 431:10A-134,
431:10A-140, and [431:10A-134,] 431:10A- , and
chapter 431M."
SECTION 4. The benefit to be provided by health maintenance organizations corresponding to the benefit provided under section 431:10A- , Hawaii Revised Statutes, as contained in the amendment to section 432D-23, Hawaii Revised Statutes, in section 3 of this Act, shall take effect for all policies, contracts, plans, or agreements issued or renewed in the State on or after December 31, 2026.
SECTION 5. Statutory material to be repealed is bracketed and stricken. New statutory material is underscored.
SECTION 6. This Act shall take effect on July 1, 3000.
Report Title:
Insurance; Mandatory Coverage; Standard Fertility Preservation Services; Iatrogenic Infertility; Medically Necessary Treatment
Description:
For policies, contracts, plans, and agreements issued or renewed after 12/31/2026, requires insurers, mutual benefit societies, and health maintenance organizations to provide coverage for standard fertility preservation services for persons undergoing medically necessary treatment that may cause iatrogenic infertility. Effective 7/1/3000. (HD1)
The summary description
of legislation appearing on this page is for informational purposes only and is
not legislation or evidence of legislative intent.